News

LOG Pharma Introduces Eco-Friendly Packaging Solutions in Europe

LOG Pharma Introduces Eco-Friendly Packaging Solutions in Europe

LOG Pharma Unveils Eco Barrier Packaging at Pharmapack Europe 2026

The company's next generation barrier technology is designed to support stability, efficiency, and sustainability goals.

LOG Pharma Primary Packaging will showcase its advanced sustainable pharmaceutical packaging solutions at Pharmapack Europe 2026, a prominent event taking place in January in Paris, France.

At Hall 4, Stand B28, attendees can explore Eco barrier, which is part of LOG's extensive lineup of primary medicine packaging solutions. This innovative product has also been chosen for the Pharmapack Product Spotlight Gallery, a dedicated exhibit area featuring groundbreaking solutions that are shaping the industry's future.

Eco is engineered to deliver exceptional performance while utilizing responsible materials. By leveraging Dow HEALTH+ pharma-grade resins, Eco meets the needs of manufacturers focusing on moisture and oxygen protection in a lighter, resource-efficient container. The innovative bottle structure offers a remarkable 30 percent weight reduction compared to traditional standard bottles, ensuring strong barrier performance without compromising the protection required for sensitive formulations.

In addition, Eco’s optimized multilayer structure significantly lowers bottle costs by over 50%, enabling pharmaceutical companies to simplify their stability planning. This, in turn, helps reduce dependence on desiccants or oxygen scavengers, ultimately accelerating the formulation development process.

"Eco represents our commitment to practical sustainability," said Noam Nahari, VP of Marketing and Business Development at LOG Pharma. "It provides pharmaceutical companies with the protection they expect while supporting them in minimizing material use and their overall environmental impact. Pharmapack Europe is the ideal venue to demonstrate what this technology can accomplish."

As the pharmaceutical packaging industry evolves, it must confront the increasing challenges posed by active pharmaceutical ingredients (APIs) that are sensitive to moisture and oxygen. Notably, LOG's data indicates that up to 90% of APIs are affected by moisture sensitivity. LOG’s comprehensive portfolio is designed to address this issue, featuring advanced solutions for both solids and liquids, tailored in sizes ranging from 15 ml to 1500 ml.

About LOG Pharma Primary Packaging

LOG Pharma Primary Packaging has been a trusted partner for the global pharmaceutical industry for over 50 years, providing a broad spectrum of standard and customized packaging solutions. With manufacturing facilities in Israel and Hungary, the company is a proud member of the Perlen Packaging group.

For additional details and to arrange a meeting at Pharmapack Europe 2026, interested parties can visit the official website.

Contact

Noam Nahari
VP Marketing & Business Development
LOG Pharma Primary Packaging
+972-50-7429429

Frequently Asked Questions

What is Eco barrier packaging?

Eco barrier packaging is an advanced sustainable packaging solution designed to offer high performance while reducing material use and environmental impact.

Where will LOG Pharma be exhibiting?

LOG Pharma will be exhibiting at Pharmapack Europe 2026, located in Hall 4, Stand B28 in Paris.

What are the benefits of the Eco packaging?

Eco packaging provides moisture and oxygen protection, weighs 30% less than standard bottles, and reduces costs by over 50%.

Who is the target audience for LOG Pharma's products?

LOG Pharma's products primarily cater to pharmaceutical manufacturers seeking reliable and sustainable packaging solutions for their products.

How long has LOG Pharma been in the industry?

LOG Pharma has served the global pharmaceutical industry for over 50 years, delivering a wide range of packaging solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Scorpius Holdings Boosts Efficiency with New Cost Reduction Plan

Updated Category News Views 183

Scorpius Holdings Implements Significant Cost-Saving Strategies Scorpius Holdings, Inc. (NYSE American: SCPX), a notable player in the biomanufacturing landscape, has recently introduced a series of strategic cost-saving measures. These initiatives aim to reduce operational costs by more than $2 million annually, showcasing the company's commitment to enhancing its...

Continue Reading
McKesson's Strategic Shift: Selling Rexall and Well.ca

Updated Category News Views 122

McKesson Corporation Expands Focus on Healthcare Services IRVING, Texas - McKesson Corporation (NYSE: MCK), a leader in healthcare services with a market capitalization of $72.45 billion and annual revenue exceeding $330 billion, has officially completed the sale of its Rexall and Well.ca businesses to Birch Hill Equity Partners. This noteworthy decision allows McKesson...

Continue Reading
GSI Group Enhances Market with GenesisBPS Acquisition

Updated Category News Views 155

GSI Group Strengthens Its Portfolio GSI Group Holdings has made a significant move by acquiring GenesisBPS, an innovative designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables. This acquisition enhances GSI Group's expanding global sales platform, reinforcing its commitment to serving the life sciences, research and...

Continue Reading
Forecasting Growth in the Antidepressant Drugs Market

Updated Category News Views 156

Understanding the Antidepressant Drugs Market The Antidepressant Drugs Market is anticipated to undergo significant growth, with a projection to reach USD 26.9 billion by 2033. This upward trend reflects a compound annual growth rate (CAGR) of 3.3% from 2024 to 2033, highlighting the increasing reliance on these medications to treat depression. Antidepressants are...

Continue Reading
Inceptio Technology Introduces Strategic Vision for L4 Trucks

Updated Category News Views 227

A Visionary Approach to L4 Autonomous Trucking by Inceptio Technology Inceptio Technology is making significant strides in the field of autonomous trucking, sharing its detailed strategy for scaling Level 4 (L4) autonomous trucks. The company recently took center stage at the Next Truck 2025 conference, demonstrating its commitment to reshaping the future of...

Continue Reading